View Older Stories View More Recent Stories

May 28, 2025 04:09PM ORIC Pharmaceuticals Inc. (ORIC) Announces $125 Million Private Placement at $6.50/sh
May 28, 2025 04:05PM ORIC® Pharmaceuticals Announces $125 Million Private Placement Financing
May 22, 2025 05:00PM Mythic Therapeutics to Present Compelling Efficacy Data from Phase 1 KisMET-01 Study Supporting Best-in-Class Potential of Investigational cMET ADC, MYTX-011, in Non-Small Cell Lung Cancer
May 15, 2025 04:39PM Form SCHEDULE 13G/A Trevi Therapeutics, Inc. Filed by: VIKING GLOBAL INVESTORS LP
May 15, 2025 04:39PM Form SCHEDULE 13G/A Oric Pharmaceuticals, Filed by: VIKING GLOBAL INVESTORS LP
May 15, 2025 04:39PM Form SCHEDULE 13G/A Roivant Sciences Ltd. Filed by: VIKING GLOBAL INVESTORS LP
May 15, 2025 04:38PM Form SCHEDULE 13G ACUREN CORP Filed by: VIKING GLOBAL INVESTORS LP
May 15, 2025 03:48PM Form 13F-HR VIKING GLOBAL INVESTORS For: Mar 31
May 1, 2025 08:00AM Mythic Therapeutics to Present Updated Dose Escalation Data from Phase 1 KisMET-01 Study on MYTX-011 at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 29, 2025 09:15PM Canopy Secures $70 Million Series C to Unclunk Accounting Firms with AI
Apr 29, 2025 04:00AM DEBRA Research Announces Impact Investment into Nova Anchora to Advance Protein Therapy for Epidermolysis Bullosa
Apr 28, 2025 03:00PM Mythic Therapeutics Presents Preclinical Data Demonstrating Potent Efficacy of MYTX-011 Across a Broad Range of Tumor Xenograft Models Harboring Clinically Relevant Mutations at the American Associati
Apr 18, 2025 09:45AM Form SCHEDULE 13G REGAL REXNORD CORP Filed by: VIKING GLOBAL INVESTORS LP
Apr 3, 2025 08:00AM Neurona Therapeutics Raises $102 Million to Fuel NRTX-1001 Phase 3 EPIC Epilepsy Trial and Advance Regenerative Cell Therapy Pipeline
Apr 2, 2025 11:38AM Revive Environmental and Battelle Partner on DoD-Funded Project to Eliminate Toxic “Forever Chemicals”
Mar 26, 2025 08:55AM Pearl Health Achieves HITRUST r2 Certification Demonstrating the Highest Level of Information Protection Assurance
Mar 26, 2025 07:27AM Areteia Therapeutics Announces Appointments of Donald J. Hayden, Jr. and Ian F. Smith to Its Board of Directors
Mar 25, 2025 12:18PM North Carolina Selects Revive Environmental for Statewide PFAS Destruction in AFFF Take-Back Program
Mar 20, 2025 02:25PM Revive Environmental Welcomes Douglas Hendry as Chief Technology Officer
Mar 18, 2025 10:00AM Patina Launches New Service, Patina Total Health (TM), to Make Personalized, Age-Friendly Care Accessible to Medicare Advantage Members
Mar 12, 2025 04:28PM Form SCHEDULE 13D/A BridgeBio Pharma, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Mar 12, 2025 04:27PM Form SCHEDULE 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2025 04:58PM Form SCHEDULE 13G Sionna Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2025 04:51PM Form SCHEDULE 13G/A NewAmsterdam Pharma Co Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2025 04:51PM Form SCHEDULE 13G/A Longboard Pharmaceutical Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2025 04:50PM Form SCHEDULE 13G/A APi Group Corp Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2025 03:48PM Hedge fund Viking buys Boeing shares, adds more JPMorgan, filing shows
Feb 14, 2025 03:20PM Form 13F-HR VIKING GLOBAL INVESTORS For: Dec 31
Feb 11, 2025 08:04AM TruBridge (TBRG) Announces Two Directors to Join Its Board as a Part of Cooperation Agreements With Pinetree Capital and Ocho Investments
Feb 11, 2025 08:00AM TruBridge Announces Two Directors to Join Its Board as a Part of Cooperation Agreements With Pinetree Capital and Ocho Investments
Jan 31, 2025 07:19PM Form SCHEDULE 13D/A BridgeBio Pharma, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Jan 31, 2025 07:18PM Form 144 BridgeBio Pharma, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Jan 14, 2025 09:00AM DeepScribe and Pearl Health Announce Partnership to Bring Ambient AI Documentation to Value-based Care Providers
Jan 9, 2025 07:27AM Areteia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday January 14, 2025
Jan 8, 2025 08:55AM Virginia Care Partners, an HCA Virginia Affiliate, and Pearl Health Establish Partnership to Expand Access to Value-Based Care
Dec 26, 2024 03:20PM Valsoft Corporation Secures $150M to Further Accelerate Growth in Vertical Market Software Sector
Dec 17, 2024 09:05AM GondolaBio and n-Lorem Foundation Partner to Advance Novel ASO Therapies for Genetic Diseases
Dec 6, 2024 12:00PM Neurona Therapeutics Presents Positive Clinical Update: New Data from NRTX-1001 Cell Therapy Trial in Drug-Resistant Epilepsy Announced at 2024 Annual Meeting of the American Epilepsy Society
Nov 26, 2024 11:00AM ID.me Announces Closing of Secondary Tender
Nov 14, 2024 04:33PM Form SC 13G/A Tourmaline Bio, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Nov 14, 2024 04:33PM Form SC 13G/A Ginkgo Bioworks Holdings Filed by: VIKING GLOBAL INVESTORS LP
Nov 14, 2024 04:32PM Form SC 13G/A Roivant Sciences Ltd. Filed by: VIKING GLOBAL INVESTORS LP
Nov 14, 2024 04:32PM Form SC 13G/A PepGen Inc. Filed by: VIKING GLOBAL INVESTORS LP
Nov 14, 2024 04:32PM Form SC 13G/A Edgewise Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP
Nov 14, 2024 04:32PM Form SC 13G/A 4D Molecular Therapeutic Filed by: VIKING GLOBAL INVESTORS LP
Nov 14, 2024 04:31PM Form SC 13G/A Viking Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP
Nov 14, 2024 04:31PM Form SC 13G/A Verastem, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Nov 14, 2024 04:01PM Form 13F-HR VIKING GLOBAL INVESTORS For: Sep 30
Nov 14, 2024 01:51PM Tesla, financials and other 'Trump trades' drew funds in Q3, filings show
Nov 13, 2024 07:00AM Metsera Secures $215 Million Series B Financing to Further Accelerate Portfolio
View More Recent Stories View Older Stories